Subscribe To Our Newsletter
Subscribe To Our Newsletter

GFO Issue 98,   Article Number: 2

Share:

ROUND EIGHT RESULTS, BY COUNTRY

N/A

Article Type:
News
     Author:
Bernard Rivers
     Date: 2008-11-09

ABSTRACT

ABSTRACT A detailed listing and analysis is provided of which Round 8 proposals have been approved.

Based on advice from the TRP, the Board divided eligible Round 8 proposals into five Categories, as follows:
  • Category 1: Approved proposals requiring no or minor clarifications, which need to be provided within 8 weeks and then given a final approval by the TRP Chair and/or Vice-Chair.
  • Category 2: Proposals that are approved in principle, subject to the required clarifications being provided within a limited timeframe (6 weeks for the applicant to provide an initial detailed response to the TRP queries, and a further 3 months to obtain the final TRP approval should further clarifications be requested). The TRP Chair and Vice-Chair need to give final approval.
  • Category 2B: Proposals that are treated as those in Category 2, but are regarded as being relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation.
  • Category 3: Proposals not approved in their present form, though applicants are encouraged to resubmit in Round 9 following major revision.
  • Category 4: Proposals that are rejected, with applicants not encouraged to resubmit in any similar form.
  The Board approved "in principle" (to use its precise words) all proposals in Categories 1, 2 and 2B. However, some of the approvals are immediate and some are delayed, depending on future availability of funds. The prioritization is handled as follows:
  • Category 1 proposals are approved immediately.
  • Each country submitting a Category 2 or 2B proposal is assigned a disease burden index of 4 or 1 according to whether the disease burden is "very high" or not "very high". And each such country is assigned a poverty index of 4, 2 or 0 according to whether the country is low income, lower-middle income, or upper-middle income. The sum of these two indexes creates the Composite Index, whose value is therefore between 8 and 1. The higher the country's Composite Index, the sooner its Category 2 or 2B proposal will be approved.
  • Category 2 proposals with a Composite Index of 8, 6 or 5 are immediately approved.
  • Remaining Category 2 and 2B proposals will be approved in the following order, as pledges by donors to the Fund become available in the course of 2008-9:
1. Category 2, Composite Index 3 2. Category 2B, Composite Index 8 3. Category 2B, Composite Index 6 4. Category 2B, Composite Index 5 5. Category 2B, Composite Index 3   The number of Round 8 grants per Category and Composite Index are as follows:

Table 4: Round 8 results by Category and Composite Index

 

Category and Composite Index

Number of proposals

Amount requested (Years 1-2)
Immediate approval: Category 1

16

USD 0.45 b.
Immediate approval: Category 2, Composite Index 8, 6 or 5

43

USD 1.68 b.
Delayed approval: Category 2, Composite Index 3

8

USD 0.18 b.
Delayed approval: Category 2B, Composite Index 8

6

USD 0.44 b.
Delayed approval: Category 2B, Composite Index 6

6

USD 0.10 b.
Delayed approval: Category 2B, Composite Index 5

8

USD 0.13 b.
Delayed approval: Category 2B, Composite Index 3

7

USD 0.09 b.
Subtotal: All Approved Proposals:

94

USD 3.06 b.
Not Approved: Category 3

63

USD 1.75 b.
Not Approved: Category 4

17

USD 0.43 b.
Not Approved: Removed sub-components of approved proposals

n/a

USD 0.56 b.
Subtotal: All Non-Approved Proposals:

80

USD 2.73 b.
Total: All Proposals

174

USD 5.79 b.
    Round 8 results by applicant were as in Tables 5 and 6, below.  

Table 5: Round 8 Results, by Country

 

Country

Disease component

Applicant

Decision

Category

(defined above)

Composite Index

(defined above)

Amount requested (Years 1-2)

Amount requested (Years 1-5)
Afghanistan Malaria (disease part + HSS part)

CCM

 Delayed approval

2B

5

EUR 30,075,545

EUR 55,397,259
Afghanistan TB

CCM

 Immediate approval

1

n/a

EUR 7,394,272

EUR 22,669,094
Algeria HIV

CCM

 Not approved

4

n/a

USD 15,252,168

USD 32,720,961
Angola HIV

CCM

 Not approved

4

n/a

USD 75,142,046

USD 235,955,998
Angola TB

CCM

 Not approved

4

n/a

USD 11,756,766

USD 25,098,444
Armenia HIV (HSS part)

CCM

 Immediate approval

2

6

EUR 1,466,930

EUR 2,062,995
Armenia HIV (disease part)

CCM

 Not approved

n/a

n/a

EUR 2,394,212

EUR 6,257,962
Armenia TB

CCM

 Immediate approval

1

n/a

EUR 2,006,371

EUR 6,205,708
Bangladesh HIV

CCM

 Not approved

3

n/a

USD 14,964,866

USD 48,892,309
Bangladesh Malaria

CCM

 Not approved

3

n/a

USD 22,729,707

USD 68,436,372
Bangladesh TB (disease part + HSS part)

CCM

 Immediate approval

2

8

USD 5,627,763

USD 77,430,875
Belarus HIV (disease part + HSS part)

CCM

 Immediate approval

1

n/a

EUR 11,120,812

EUR 25,389,385
Belarus TB

CCM

 Not approved

3

n/a

EUR 14,254,281

EUR 31,226,265
Benin Malaria

CCM

 Not approved

3

n/a

EUR 26,909,499

EUR 26,909,499
Benin TB

CCM

 Not approved

3

n/a

EUR 3,556,947

EUR 6,658,804
Bolivia HIV

CCM

 Not approved

3

n/a

USD 7,763,930

USD 23,802,395
Bolivia Malaria

CCM

 Delayed approval

2B

3

USD 6,744,407

USD 15,578,630
Bolivia TB

CCM

 Not approved

4

n/a

USD 9,191,385

USD 16,777,841
Bosnia & Herzegovina HIV

CCM

 Not approved

3

n/a

EUR 12,336,077

EUR 29,441,571
Bosnia & Herzegovina TB

CCM

 Not approved

3

n/a

EUR 5,722,028

EUR 9,796,973
Brazil HIV

CCM

 Not approved

3

n/a

EUR 9,372,000

EUR 30,000,000
Brazil Malaria

CCM

 Delayed approval

2

3

EUR 20,659,117

EUR 42,023,909
Brazil TB

CCM

 Not approved

3

n/a

EUR 40,191,174

EUR 80,560,970
Bulgaria TB

CCM

 Delayed approval

2B

3

EUR 3,661,435

EUR 10,527,766
Burkina Faso HIV

CCM

 Not approved

3

n/a

EUR 24,844,539

EUR 48,473,676
Burkina Faso Malaria

CCM

 Immediate approval

2

8

EUR 53,120,303

EUR 63,203,438
Burkina Faso TB (disease part + HSS part)

CCM

 Delayed approval

2B

8

EUR 12,045,997

EUR 27,167,685
Burundi HIV

CCM

 Delayed approval

2B

8

USD 41,315,145

USD 159,105,087
Cambodia HIV

CCM

 Not approved

3

n/a

USD 38,283,888

USD 134,514,948
Cambodia TB (disease part + HSS part)

CCM

 Not approved

3

n/a

USD 11,449,113

USD 34,686,505
Cameroon HIV

CCM

 Not approved

3

n/a

EUR 28,961,003

EUR 66,797,527
Cameroon TB

CCM

 Not approved

3

n/a

EUR 7,015,400

EUR 13,782,656
Cape Verde HIV

CCM

 Delayed approval

2

3

USD 5,321,184

USD 12,578,727
Central African Republic Malaria

CCM

 Immediate approval

2

8

EUR 10,871,833

EUR 30,971,995
Central African Republic TB

CCM

 Not approved

3

n/a

EUR 9,742,228

EUR 22,482,120
Chad HIV

CCM

 Immediate approval

2

8

EUR 29,702,927

EUR 63,244,477
Chad TB

CCM

 Delayed approval

2B

8

EUR 3,427,453

EUR 5,385,007
China HIV

CCM

 Immediate approval

2

6

EUR 15,747,191

EUR 44,128,188
China Malaria

CCM

 Not approved

3

n/a

EUR 29,681,060

EUR 61,332,628
China TB

CCM

 Delayed approval

2B

6

EUR 24,012,517

EUR 87,664,363
Colombia HIV

CCM

 Not approved

3

n/a

EUR 12,254,560

EUR 32,867,073
Colombia Malaria

CCM

 Delayed approval

2

3

EUR 16,997,092

EUR 32,262,166
Colombia TB

CCM

 Not approved

3

n/a

EUR 11,968,726

EUR 22,919,271
Comoros HIV

CCM

 Not approved

4

n/a

EUR 1,235,586

EUR 2,229,001
Comoros Malaria (disease part)

CCM

 Immediate approval

2

5

EUR 5,280,932

EUR 11,788,954
Comoros Malaria (HSS part)

CCM

 Not approved

n/a

n/a

EUR 1,061,171

EUR 2,834,024
Congo (Democratic Republic of) HIV

CCM

 Immediate approval

2

8

USD 79,225,696

USD 262,911,091
Congo (Democratic Republic of) Malaria

CCM

 Immediate approval

2

8

USD 153,997,553

USD 393,102,357
Congo (Democratic Republic of) TB (disease part + HSS part)

CCM

 Not approved

3

n/a

USD 71,422,674

USD 199,682,709
Congo (Republic of) Malaria

CCM

 Delayed approval

2B

6

EUR 25,465,537

EUR 54,135,175
Congo (Republic of) TB

CCM

 Delayed approval

2B

6

EUR 2,303,089

EUR 5,005,041
Cote d'Ivoire HIV (disease part + HSS part)

CCM

 Not approved

3

n/a

EUR 55,758,904

EUR 142,745,182
Cote d'Ivoire Malaria

CCM

 Immediate approval

2

8

EUR 139,365,869

EUR 180,298,316
Cote d'Ivoire TB

CCM

 Not approved

3

n/a

EUR 7,152,767

EUR 17,886,903
Djibouti Malaria

CCM

 Not approved

3

n/a

EUR 4,335,600

EUR 10,391,353
Djibouti TB

CCM

 Not approved

4

n/a

EUR 3,912,029

EUR 8,688,954
Dominican Republic Malaria

CCM

 Delayed approval

2

3

USD 4,492,517

USD 8,703,257
Ecuador HIV

CCM

 Not approved

3

n/a

USD 14,389,246

USD 35,615,171
Ecuador Malaria

CCM

 Delayed approval

2

3

USD 8,374,965

USD 15,108,812
Ecuador TB

CCM

 Not approved

3

n/a

USD 14,066,522

USD 32,819,024
Eritrea HIV (disease part)

CCM

 Immediate approval

2

8

USD 17,071,740

USD 45,135,676
Eritrea HIV (HSS part)

CCM

 Not approved

n/a

n/a

USD 6,087,808

USD 14,939,526
Ethiopia Malaria (disease part + HSS part)

CCM

 Immediate approval

1

n/a

USD 148,412,502

USD 291,064,713
Fiji TB (disease part + HSS part)

CCM

 Delayed approval

2B

3

USD 4,789,119

USD 9,929,474
Gabon HIV

CCM

 Immediate approval

1

n/a

EUR 6,879,029

EUR 17,006,207
Gabon Malaria

CCM

 Not approved

3

n/a

EUR 5,030,319

EUR 13,851,883
Gambia HIV (disease part + HSS part)

CCM

 Immediate approval

2

5

EUR 15,250,763

EUR 36,582,801
Ghana HIV

CCM

 Immediate approval

2

8

USD 51,498,200

USD 99,858,800
Ghana Malaria (disease part)

CCM

 Immediate approval

2

8

USD 39,639,118

USD 158,030,372
Ghana Malaria (HSS part)

CCM

 Not approved

n/a

n/a

USD 4,462,500

USD 13,420,570
Guatemala HIV (disease part + HSS part)

CCM

 Not approved

4

n/a

EUR 37,104,756

EUR 115,595,987
Guatemala Malaria

CCM

 Not approved

3

n/a

EUR 21,586,329

EUR 41,174,990
Guinea-Bissau TB (HSS part)

CCM

 Immediate approval

2

5

EUR 595,684

EUR 1,286,514
Guinea-Bissau TB (disease part)

CCM

 Not approved

n/a

n/a

EUR 7,818,909

EUR 21,213,426
Guyana HIV (HSS part)

CCM

 Immediate approval

2

6

USD 4,637,491

USD 10,094,303
Guyana HIV (disease part)

CCM

 Not approved

n/a

n/a

USD 6,005,402

USD 18,370,517
Guyana Malaria

CCM

 Not approved

3

n/a

USD 2,993,178

USD 5,573,355
Guyana TB

CCM

 Delayed approval

2B

3

USD 3,087,615

USD 7,125,899
Haiti Malaria

CCM

 Delayed approval

2B

5

USD 33,402,457

USD 50,046,179
Haiti TB (disease part + HSS part)

CCM

 Not approved

3

n/a

USD 31,167,222

USD 59,742,348
Honduras HIV

CCM

 Not approved

3

n/a

USD 5,334,334

USD 13,389,159
Honduras TB (disease part + HSS part)

CCM

 Not approved

3

n/a

USD 8,031,166

USD 16,170,525
India HIV

CCM

 Not approved

3

n/a

EUR 21,263,481

EUR 75,212,496
India Malaria

CCM

 Not approved

3

n/a

EUR 39,883,180

EUR 100,310,326
India TB

CCM

 Not approved

3

n/a

EUR 32,420,155

EUR 79,915,954
Indonesia HIV

CCM

 Immediate approval

1

n/a

USD 45,384,545

USD 130,653,560
Indonesia Malaria

CCM

 Delayed approval

2

3

USD 73,453,889

USD 120,092,536
Indonesia TB

CCM

 Immediate approval

1

n/a

USD 28,106,251

USD 93,001,059
Iran HIV

CCM

 Delayed approval

2B

6

USD 10,328,021

USD 32,354,404
Kazakhstan HIV

CCM

 Not approved

3

n/a

USD 13,880,664

USD 35,851,200
Kazakhstan Malaria

CCM

 Not approved

4

n/a

USD 897,612

USD 1,376,877
Kazakhstan TB

CCM

 Delayed approval

2B

3

USD 37,557,518

USD 69,880,919
Kenya HIV

CCM

 Not approved

4

n/a

USD 105,743,946

USD 129,929,146
Kenya Malaria

CCM

 Not approved

3

n/a

USD 89,634,705

USD 200,581,638
Kenya TB (disease part + HSS part)

CCM

 Not approved

3

n/a

USD 41,216,118

USD 137,406,953
Korea (Democratic People's Republic of) HIV

CCM

 Not approved

3

n/a

EUR 15,119,159

EUR 28,699,056
Korea (Democratic People's Republic of) Malaria

CCM

 Immediate approval

2

5

EUR 9,542,511

EUR 18,348,551
Korea (Democratic People's Republic of) TB

CCM

 Delayed approval

2B

5

EUR 17,686,423

EUR 47,102,407
Kyrgyz Republic HIV

Sub-CCM

 Not approved

4

n/a

USD 3,560,042

USD 6,770,643
Kyrgyz Republic Malaria

CCM

 Immediate approval

2

5

USD 4,530,888

USD 8,788,180
Kyrgyz Republic TB

CCM

 Not approved

3

n/a

USD 7,507,988

USD 24,622,765
Lao People's Democratic Republic HIV (disease part + HSS part)

CCM

 Immediate approval

2

8

USD 9,114,326

USD 24,569,609
Lesotho HIV (disease part + HSS part)

CCM

 Immediate approval

2

6

USD 39,773,696

USD 103,429,628
Lesotho TB

CCM

 Delayed approval

2B

6

USD 10,967,381

USD 28,083,618
Liberia HIV (disease part + HSS part)

CCM

 Immediate approval

2

8

USD 20,199,587

USD 78,235,151
Madagascar HIV

CCM

 Immediate approval

2

5

USD 11,768,300

USD 36,037,600
Madagascar TB

CCM

 Delayed approval

2B

5

USD 8,987,239

USD 22,797,620
Mali HIV (disease part)

CCM

 Immediate approval

2

8

EUR 40,526,846

EUR 126,634,447
Mali HIV (HSS part)

CCM

 Not approved

n/a

n/a

EUR 21,852,585

EUR 49,979,708
Mauritania HIV (HSS part)

CCM

 Immediate approval

1

n/a

USD 2,772,376

USD 3,942,505
Mauritania HIV (disease part)

CCM

 Not approved

n/a

n/a

USD 9,367,617

USD 22,266,256
Mauritius HIV

CCM

 Immediate approval

1

n/a

EUR 4,052,662

EUR 7,890,632
Moldova HIV

CCM

 Delayed approval

2B

6

EUR 8,606,392

EUR 16,723,816
Moldova TB

CCM

 Immediate approval

1

n/a

EUR 5,281,042

EUR 13,322,904
Mozambique HIV (HSS part)

CCM

 Immediate approval

2

8

USD 13,177,452

USD 34,874,346
Mozambique HIV (disease part)

CCM

 Not approved

n/a

n/a

USD 39,073,131

USD 170,770,762
Mozambique Malaria

CCM

 Not approved

3

n/a

USD 78,152,630

USD 210,466,897
Namibia HIV

CCM

 Not approved

3

n/a

USD 64,688,284

USD 160,505,034
Nepal HIV (disease part + HSS part)

CCM

 Not approved

3

n/a

USD 35,249,649

USD 90,220,063
Nicaragua HIV

CCM

 Delayed approval

2

3

USD 31,385,337

USD 65,390,510
Nigeria HIV (HSS part)

CCM

 Immediate approval

2

8

USD 75,055,363

USD 178,030,052
Nigeria HIV (disease part)

CCM

 Not approved

n/a

n/a

USD 293,867,577

USD 831,612,641
Nigeria Malaria

CCM

 Delayed approval

2B

8

USD 334,351,033

USD 599,810,494
Nigeria TB

CCM

 Not approved

3

n/a

USD 42,169,586

USD 181,584,855
Pakistan HIV

CCM

 Not approved

3

n/a

USD 18,636,708

USD 66,219,051
Pakistan TB

CCM

 Immediate approval

2

8

USD 9,810,559

USD 26,682,133
Panama HIV

CCM

 Not approved

3

n/a

USD 4,949,840

USD 13,592,440
Papua New Guinea Malaria

CCM

 Immediate approval

2

5

USD 70,139,822

USD 152,252,244
Paraguay HIV (disease part)

CCM

 Immediate approval

2

6

EUR 4,765,763

EUR 13,314,074
Paraguay HIV (HSS part)

CCM

 Not approved

n/a

n/a

EUR 1,514,597

EUR 3,267,216
Paraguay Malaria

CCM

 Not approved

3

n/a

EUR 4,403,483

EUR 8,558,518
Paraguay TB

CCM

 Not approved

3

n/a

EUR 8,277,793

EUR 18,576,825
Peru HIV (disease part + HSS part)

CCM

 Not approved

3

n/a

EUR 30,545,347

EUR 50,546,403
Peru TB

CCM

 Immediate approval

1

n/a

EUR 11,484,622

EUR 22,229,143
Philippines HIV (disease part + HSS part)

CCM

 Not approved

3

n/a

EUR 25,581,667

EUR 42,391,843
Russian Federation TB

CCM

 Not approved

3

n/a

EUR 65,687,022

EUR 139,199,580
Russian Federation TB (disease part + HSS part)

Sub-CCM

 Not approved

4

n/a

EUR 18,808,972

EUR 33,180,557
Rwanda HIV

CCM

 Not approved

3

n/a

USD 15,591,988

USD 38,979,970
Rwanda Malaria (disease part)

CCM

 Immediate approval

2

5

USD 58,567,001

USD 138,469,243
Rwanda Malaria (HSS part)

CCM

 Not approved

n/a

n/a

USD 33,702,875

USD 48,541,601
Sao Tome and Principe HIV

CCM

 Not approved

3

n/a

USD 568,464

USD 1,529,157
Sao Tome and Principe TB

CCM

 Immediate approval

1

n/a

USD 1,132,914

USD 2,608,818
Senegal HIV (disease part + HSS part)

CCM

 Not approved

3

n/a

EUR 54,507,488

EUR 136,440,454
Senegal TB

CCM

 Not approved

3

n/a

EUR 6,930,243

EUR 17,791,333
Serbia HIV

CCM

 Delayed approval

2

3

EUR 3,766,988

EUR 12,406,231
Solomon Islands HIV (disease part)

CCM

 Not approved

n/a

n/a

USD 4,570,062

USD 10,472,323
Solomon Islands HIV (HSS part)

CCM

 Delayed approval

2B

5

USD 845,725

USD 1,686,884
Solomon Islands TB

CCM

 Delayed approval

2B

5

USD 3,608,714

USD 7,334,716
Somalia HIV (disease part + HSS part)

Non-CCM

 Immediate approval

2

5

USD 25,669,049

USD 60,261,684
South Africa HIV

CCM

 Not approved

3

n/a

USD 91,680,358

USD 259,056,796
South Africa TB

CCM

 Not approved

4

n/a

USD 68,229,369

USD 194,670,986
Sri Lanka Malaria

CCM

 Delayed approval

2B

3

USD 24,040,444

USD 40,915,151
Sudan (Northern Sector) TB (disease part + HSS part)

CCM

 Delayed approval

2B

8

USD 17,979,663

USD 58,048,795
Sudan (Southern Sector) HIV (disease part + HSS part)

Sub-CCM

 Not approved

3

n/a

USD 28,482,979

USD 124,015,542
Swaziland HIV (HSS part)

CCM

 Immediate approval

2

6

USD 8,180,726

USD 15,136,442
Swaziland HIV (disease part)

CCM

 Not approved

n/a

n/a

USD 49,055,285

USD 90,214,010
Swaziland Malaria

CCM

 Immediate approval

1

n/a

USD 5,637,713

USD 13,880,938
Swaziland TB

CCM

 Immediate approval

2

6

USD 4,785,540

USD 11,839,346
Tajikistan HIV

CCM

 Immediate approval

2

8

EUR 13,264,761

EUR 34,578,129
Tajikistan Malaria

CCM

 Immediate approval

2

5

EUR 5,224,796

EUR 9,615,246
Tajikistan TB (disease part + HSS part)

CCM

 Immediate approval

2

5

EUR 9,840,404

EUR 17,534,572
Tanzania (United Republic of) HIV (disease part)

CCM

 Immediate approval

2

8

USD 145,848,085

USD 598,106,619
Tanzania (United Republic of) HIV (HSS part)

CCM

 Not approved

n/a

n/a

USD 65,422,207

USD 96,794,019
Tanzania (United Republic of) Malaria

CCM

 Immediate approval

2

5

USD 111,586,404

USD 113,335,025
Thailand HIV

CCM

 Immediate approval

2

6

USD 38,254,259

USD 106,123,200
Thailand TB

CCM

 Immediate approval

1

n/a

USD 12,420,804

USD 30,547,583
Togo HIV

CCM

 Immediate approval

2

8

EUR 31,775,839

EUR 81,340,190
Tunisia TB

CCM

 Delayed approval

2B

3

USD 4,400,014

USD 7,560,548
Turkmenistan TB

CCM

 Not approved

3

n/a

USD 10,649,147

USD 20,279,651
Ukraine TB

CCM

 Not approved

3

n/a

USD 36,251,905

USD 94,715,697
Uruguay HIV

CCM

 Not approved

3

n/a

USD 8,951,242

USD 21,393,157
Uzbekistan HIV

CCM

 Not approved

3

n/a

USD 26,428,887

USD 79,669,868
Uzbekistan Malaria

CCM

 Delayed approval

2B

5

USD 2,789,923

USD 6,144,821
Uzbekistan TB

CCM

 Delayed approval

2B

5

USD 13,881,631

USD 56,124,183
Vietnam HIV

CCM

 Immediate approval

2

8

USD 14,577,204

USD 48,693,061
West Bank and Gaza TB

Non-CCM

 Immediate approval

1

n/a

EUR 972,386

EUR 2,152,074
Yemen HIV

CCM

 Not approved

3

n/a

USD 6,495,225

USD 25,735,775
Yemen TB

CCM

 Not approved

4

n/a

USD 6,767,022

USD 19,880,527
Zambia HIV (disease part + HSS part)

CCM

 Immediate approval

1

n/a

USD 144,079,863

USD 307,273,164
Zanzibar HIV

CCM

 Not approved

4

n/a

EUR 4,127,078

EUR 7,274,018
Zanzibar Malaria (disease part + HSS part)

CCM

 Immediate approval

2

5

EUR 5,648,340

EUR 12,355,905
Zimbabwe HIV

CCM

 Immediate approval

2

8

USD 86,821,730

USD 296,752,070
Zimbabwe Malaria (disease part + HSS part)

CCM

 Immediate approval

2

5

USD 70,994,472

USD 141,316,927
Zimbabwe TB

CCM

 Delayed approval

2B

8

USD 29,538,652

USD 58,298,297
 

Table 6: Round 8 results for regional applicants

 

Country

Disease

Applicant

 Decision

Category (defined above)

Composite Index (defined above)

Requested (Years 1-2)

Requested (Years 1-5)
CARE (India, Nepal, Bangladesh) HIV

Regional organization

 Not approved

4

n/a

EUR 14,145,331

EUR 40,817,080
CCLAB (Guatemala, El Salvador, Honduras, Nicaragua, Dom. Rep., Panama, Costa Rica, Belize) HIV

Regional Coordinating Mechanism

 Not approved

4

n/a

USD 20,292,270

USD 46,811,258
COPRECOS LAC (Colombia, El Salvador, Nicaragua, Panama, Paraguay, Dom. Rep., Uruguay, Argentina, Belize, Brazil, Ecuador, Guatemala, Haiti, Honduras, Peru, Chile, Costa Rica, Venezuela) HIV

Regional organization

 Not approved

3

n/a

USD 23,122,297

USD 68,666,796
GLIA (Burundi, DRC, Kenya, Rwanda, Tanzania, Uganda) HIV

Regional organization

 Not approved

4

n/a

USD 10,824,037

USD 27,044,765
SADC (Angola, Botswana, Namibia, Zambia, Zimbabwe) Malaria (disease part + HSS part)

Regional Coordinating Mechanism

 Not approved

3

n/a

USD 36,018,686

USD 86,985,372

Publication Date: 2008-11-09


Tags:

Leave a reply

  • Comments

Your email address will not be published.

Archives

Archive

Other Articles from this Issue

Article Number: 1

GLOBAL FUND APPROVES ROUND 8 GRANTS, BUT CUTS BUDGETS AND DELAYS ROUND 9

2008-11-09

Article Number: 3

BOARD DECISION NEWS FORTHCOMING

2008-11-09

Twitter

Facebook

Aidspan

Categories*
Aidspan

Catégories*

Original text
Rate this translation
Your feedback will be used to help improve Google Translate